Overview
Subscribe
VC Statistics
Back to VC Home
MedTRACK
MedTRACK Japan
Report Center


MedTRACK Brochure Sample Transaction Report
 

Welcome to the MedTRACK Venture Finance Database. The Venture Finance Database provides comprehensive coverage of over 8,000 Venture rounds and other details for more than 3,000 biomedical companies covered in MedTRACK. The MedTRACK Venture Finance Database is the industry leader for breadth and depth of Venture Finance coverage.

Search by

  • Company Name
  • Firm Name
  • Venture Rounds
  • Security Types
  • Therapeutic Area
  • Keyword
  • Advanced Search

  • and more...

The MedTRACK Venture Finance Database also contains the latest Venture Financing News, available SEC documents relating to each Financing and a clickable list of leading Venture Finance rounds of recent months.

Review the search categories below to see how a subscription to the MedTRACK Venture Finance Database can support your analysis of opportunities in the biomedical sphere.


Financing Rounds
Early Stage StartUp & Seed
Series A Series B
Series C Series D
Series E Series F
Series G Series H
Series I Series J
Series K Expansion
Mezzanine Other



Transaction Categories
Venture Financing Private Placement


Security Types
Preferred Stock Common Stock
VC Equity Investment Warrants
Debt Convertible Debt



 
 
Current Statistics
Total Transactions10997
Total Companies4516
Total Firms5641

800 James Ave.
Suite 201
Scranton, PA 18510

If you would like immediate response, you may contact directly.
Telephone:
570-504-1800
email: info@medtrack.com



 
The information contained herein is based on sources believed to be reliable but is neither all-inclusive nor guaranteed by Life Science Analytics ("LSA"). Opinions, if any, reflect the judgment of LSA at this time and are subject to change. LSA does not undertake to advise you of changes in their opinion or information. Most of the companies LSA follows are emerging growth companies whose securities typically involve a higher degree of risk and more volatility than the securities of more established companies. The securities discussed in the reports included in LSA's Database may be unsuitable for investors depending on their specific investment objectives, financial situation and needs. No report included in the LSA Database is a recommendation that any particular investor should purchase or sell any particular security in any amount or at all, and is not a solicitation of any offer to purchase or sell from or to any particular investor. For additional information that may be available on the securities mentioned, please contact Life Science Analytics.